Vitreous Cryopreservation of Human Umbilical Vein Endothelial Cells with Low Concentration of Cryoprotective Agents for Vascular Tissue Engineering.
Cryopreservation of human umbilical vein endothelial cells (HUVECs) is important to tissue engineering applications and the study of the role of endothelial cells in cardiovascular and cerebrovascular diseases. The traditional methods for cryopreservation by vitrification (cooling samples to a cryogenic temperature without apparent freezing) using high concentration of cryoprotective agents (CPAs) and slow freezing are suboptimal due to the severe toxicity of high concentration of CPAs and ice formation-induced cryoinjuries, respectively. In this study, we developed a method to cryopreserve HUVECs by vitrification with low concentration of CPAs. This is achieved by optimizing the CPAs and using highly thermally conductive quartz capillary (QC) to contain samples for vitrification. The latter minimizes the thermal mass to create ultra-fast cooling/warming rates. Our data demonstrate that HUVECs can be vitrified in the QC using 1.4 mol/L ethylene glycol and 1.1 mol/L dimethyl sulfoxide with more than 90% viability. Moreover, this method significantly improves the attachment efficiency of the cryopreserved HUVECs. The attached cells post-cryopreservation proliferate similarly to fresh cells. Therefore, this study may provide an effective vitrification technique to bank HUVECs for vascular tissue engineering and other applications.
1 Center for Biomedical Engineering, Department of Electronic Science and Technology, University of Science and Technology of China , Hefei, Anhui, China .
Yuanyuan
Y
Zheng
1 Center for Biomedical Engineering, Department of Electronic Science and Technology, University of Science and Technology of China , Hefei, Anhui, China .|2 Anhui Provincial Engineering Research Center for Biopreservation and Artificial Organs , Hefei, Anhui, China .
Gang
G
Zhao
1 Center for Biomedical Engineering, Department of Electronic Science and Technology, University of Science and Technology of China , Hefei, Anhui, China .
Fazil
F
Panhwar
3 Department of Biomedical Engineering, The Ohio State University , Columbus, Ohio.
Xiaoming
X
He
D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000494:pharmacology*; D005615:Freezing; D061307:Human Umbilical Vein Endothelial Cells / Q000166:cytology*; D006801:Humans; D013696:Temperature; D023822:Tissue Engineering / Q000379:methods*; D058989:Vitrification / Q000187:drug effects*
D003451:Cryoprotective Agents
J Int Med Res. 1995 May-Jun;23(3):200-6
7649344
Tissue Eng Part A. 2009 Aug;15(8):2029-37
19320555
Cell Biophys. 1984 Sep;6(3):197-213
6210147
Theriogenology. 2007 Jan 1;67(1):73-80
17055564
Theriogenology. 1999 Apr 1;51(5):999-1006
10729021
Cryobiology. 2014 Feb;68(1):147-51
24462541
Nat Protoc. 2007;2(3):481-5
17406610
Theriogenology. 2003 Apr 15;59(8):1839-50
12566156
Cryobiology. 2008 Jun;56(3):223-32
18462712
Tissue Eng. 2006 Dec;12(12):3439-47
17518680
J Nanobiotechnology. 2015 Mar 25;13:24
25890315
Reprod Biomed Online. 2005 Sep;11(3):300-8
16176668
Am J Physiol. 1984 Sep;247(3 Pt 1):C125-42
6383068
Nature. 2004 Mar 11;428(6979):138-9
15014486
Cryobiology. 1987 Jun;24(3):196-213
3595164
Mol Reprod Dev. 1996 Dec;45(4):503-12
8956289
Hum Reprod. 2001 Nov;16(11):2350-6
11679519
Ann N Y Acad Sci. 2005 Dec;1066:119-35
16533923
Cryobiology. 2007 Dec;55(3):222-9
17919532
Cell Cycle. 2015;14(10):1507-16
25785867
Fertil Steril. 2001 Sep;76(3):618-20
11532492
Tissue Antigens. 1997 Nov;50(5):449-58
9389318
Tissue Eng. 2006 Sep;12(9):2685-93
16995802
Hum Reprod. 1998 Oct;13(1O):2874-9
9804248
ACS Appl Mater Interfaces. 2015 Mar 4;7(8):5017-28
25679454
Nucleic Acids Res. 2015 Feb 18;43(3):e21
25414332
J Appl Crystallogr. 2006 Dec 1;39(6):805-811
20461232
Tissue Eng. 1996 Summer;2(2):85-96
19877932
Foot Ankle Int. 2004 May;25(5):303-10
15134610
Cryobiology. 1984 Aug;21(4):407-26
6467964